Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syndicate Bio is a platform biotechnology company focused on advancing genomics and precision medicine across the world's most genetically diverse regions, with a primary focus on Africa. Founded by Dr. Abasi Ene-Obong, the company leverages large-scale partnerships with governments, pharmaceutical companies, and academic institutions to generate high-quality genomic datasets. These datasets are utilized to accelerate drug discovery, identify novel therapeutic targets, and improve clinical trial efficiency for underserved populations. Syndicate Bio also provides clinical oncology services, including liquid biopsy and comprehensive genomic profiling, to enhance patient care and diagnostic accuracy on the continent.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on syndicate of highly successful entrepreneurs.